| # | Drug | Count |
|---|---|---|
| 0 | TIRZEPATIDE | 2265 |
| 1 | LISDEXAMFETAMINE | 152 |
| 2 | LISDEXAMFETAMINE DIMESYLATE | 142 |
| 3 | PREGABALIN | 136 |
| 4 | LAMOTRIGINE | 117 |
| 5 | LISDEXAMFETAMINE DIMESYLATE CAPSULES | 114 |
| 6 | ERGOCALCIFEROL | 109 |
| 7 | METHYLPHENIDATE HYDROCHLORIDE | 109 |
| 8 | LEVOTHYROXINE SODIUM | 107 |
| 9 | BUPROPION HYDROCHLORIDE | 91 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LISDEXAMFETAMINE DIMESYLATE CAPSULES | 114 | 0.0222 |
| 1 | RESMETIROM | 32 | 0.0139 |
| 2 | TIRZEPATIDE | 2265 | 0.0125 |
| 3 | INFLIXIMAB-DYYB | 43 | 0.0125 |
| 4 | ESTRADIOL VALERATE | 7 | 0.0090 |
| 5 | CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES | 55 | 0.0060 |
| 6 | SOLRIAMFETOL | 17 | 0.0044 |
| 7 | LISDEXAMFETAMINE DIMESYLATE | 142 | 0.0042 |
| 8 | BACLOFEN INJECTION | 12 | 0.0039 |
| 9 | ERGOCALCIFEROL | 109 | 0.0037 |
| # | Drug class | Count |
|---|---|---|
| 0 | GLP-1 Receptor Agonist [EPC] | 2271 |
| 1 | Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC] | 2265 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 236 |
| 3 | Benzodiazepine [EPC] | 209 |
| 4 | Corticosteroid [EPC] | 175 |
| 5 | Anti-epileptic Agent [EPC] | 155 |
| 6 | Mood Stabilizer [EPC] | 139 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 135 |
| 8 | Central Nervous System Stimulant [EPC] | 119 |
| 9 | Provitamin D2 Compound [EPC] | 109 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Thyroid Hormone Receptor beta Agonist [EPC] | 32 | 0.0139 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 12 | 0.0058 |
| 2 | GLP-1 Receptor Agonist [EPC] | 2271 | 0.0051 |
| 3 | Serotonin-4 Receptor Agonist [EPC] | 3 | 0.0046 |
| 4 | Dopamine and Norepinephrine Reuptake Inhibitor [EPC] | 17 | 0.0044 |
| 5 | Provitamin D2 Compound [EPC] | 109 | 0.0037 |
| 6 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 7 | Opioid Antagonist [EPC] | 2 | 0.0021 |
| 8 | Uric Acid-specific Enzyme [EPC] | 6 | 0.0015 |
| 9 | Estrogen Agonist/Antagonist [EPC] | 4 | 0.0015 |